Response to Regulatory Questions (RTQ)
0.1.0 - ci-build
Response to Regulatory Questions (RTQ), published by HL7 International. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/rtq-ig/ and changes regularly. See the Directory of published versions
This Implementation Guide was developed through a collaborative effort by a dedicated group of individuals who generously contributed their time and expertise.
| Name | Organisation |
|---|---|
| Craig Anderson | Johnson & Johnson |
| Organisation (Alphabetical Order) | Contributors |
|---|---|
| Cormeo & EXTEDO | Schei Dattner |
| DNANexus | Omar Serang |
| Docuvera | Murali Menon |
| European Medicines Agency (EMA) | Panagiotis Talonis |
| Glemser | James Drennan |
| Jennifer Wemstrom, Sean Hamill, Nick Losier | |
| i4i Inc | Jacqueline Bruner, Gilles Durot |
| Johnson & Johnson | Sheetal Gaiki |
| NProgram Ltd | Rik Smithies |
| Samvit Solutions | Smita Hastak |
| Veeva Systems | Crystal Allard |
RTQ is developed under the HL7's Biomedical Research and Regulation (BR&R) Working Group with active participation from regulators, pharmaceutical companies, and technology vendors.
All meetings are public; notes and recordings are available via HL7 BR&R Working Group's RTQ project page.
We welcome industry, solution providers, and regulators from every region to contribute to this global standard.